Skip Nav Destination
Issues
January/February 2023
ISSN 1537-2073
eISSN 2834-5398
Factors Associated With Treatment-Related Changes in Voice Volume in People With Multiple Sclerosis
Valeria Crispiatico, SLP; Cinzia Baldanzi, SLP; Martina Bertuletti, SLP; Silvia Grassi, SPL; Francesca Tedeschi, SPL; Elisabetta Groppo, MD; Marco Rovaris, MD; Davide Cattaneo, PhD, PT; Chiara Vitali, SLP
Prioritizing Components of a Dyadic Physical Activity Intervention for People With Moderate to Severe Multiple Sclerosis and Their Care Partners: A Modified e-Delphi Study
Afolasade Fakolade, PhD; Odessa McKenna, MSc; Rachel Kamel, BSc; Mark S. Freedman, MD; Marcia Finlayson, PhD; Amy E. Latimer-Cheung, PhD; Lara A. Pilutti, PhD
CE ARTICLE • 2023 SERIES • NUMBER 1
-
Cover Image
Cover Image
Free Content
Copyright © Consortium of Multiple Sclerosis Centers
Get Email Alerts
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters
Munther Queisi, MD, Hrayr Attarian, MD, Veronica P. Cipriani, MD, Saria Azzi, BS, Olivia Kaczmarek, BS, Barbara Bumstead, MS, Marijean Buhse, PhD, Myassar Zarif, MD, Daniel Golan, MD, Jeffrey Wilken, PhD, Thomas Covey, PhD, Mark Gudesblatt, MD
Assessment of Multiple Aspects of Upper Extremity Function Independent From Ambulation in Patients With Multiple Sclerosis
Caspar E.P. van Munster, MD, PhD, Jessica Burggraaff, MD, PhD, Saskia Steinheimer, MD, Christian P. Kamm, MD, Marcus D’Souza, MD, Manuela Diederich, MSc, Jonas Dorn, PhD, Lorcan Walsh, PhD, Frank Dahlke, MD, Ludwig Kappos, MD, PhD, Bernard M.J. Uitdehaag, MD, PhD
Using an Intervention Mapping Approach to Improve Adherence to Disease-Modifying Treatment in Multiple Sclerosis
Efrat Neter, PhD, Ariel Miller, MD, PhD
Serum Sickness/Serum Sickness–like Reactions Following Ocrelizumab Infusion in 2 Patients With Multiple Sclerosis
Nicole Bou Rjeily, MD, Bardia Nourbakhsh, MD, MAS, Ellen M. Mowry, MD, MCR
Diversity, Equity, and Inclusion in the Multiple Sclerosis Community: A Call to Action
Carrie M. Hersh, DO, MSc, Sarah A. Morrow, MD, MS, FRCPC, Mitzi Joi Williams, MD, Lilyana Amezcua, MD, MS, June Halper, MSN, APN-C, MSCN, Katherine Wandersee, BA
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review
Aliza Bitton Ben-Zacharia, PhD, DNP, ANP, MSCN, FAAN, Bryan Walker, MHS, PA-C, Amy Perrin Ross, APN, MSN, CNRN, MSCN, Carlo Tornatore, MD, Natalie C. Edwards, MSc, Yvette Lipman, PharmD, Amy L. Phillips, PharmD
Hospital Readmission Rates in Patients With Neuromyelitis Optica Spectrum Disorder
Akhil Padarti, MD, Amod Amritphale, MD, William Kilgo, MD
Innovations in Multiple Sclerosis Care: The Impact of Artificial Intelligence via Machine Learning on Clinical Research and Decision-Making
Jacob Cartwright, MS, Kristof Kipp, PhD, Alexander V. Ng, PhD, FACSM
LETTER FROM THE EDITOR
Francois Bethoux, MD
Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile Application
Sharon Stoll, DO, Charisse Litchman, MD, Noah Rubin, BS, Larry Rubin, MPh, Timothy Vartanian, MD, PhD
Effect of Foot Reflexology on Patients With Multiple Sclerosis: A Systematic Review of Current Evidence
Boopalan Deenadayalan, MD, Vijayakumar Venugopal, PhD, Ravi Poornima, BNYS, Vanamoorthy Mahesh Kannan, MSc, Anandhan Akila, MD, Chidambaram Yogapriya, BNYS, Kuppusamy Maheshkumar, PhD
Direct and Indirect Care of Patients With Multiple Sclerosis: Burden on Providers and Impact of Portal Messages
Rola Mahmoud, MD, Katie Callahan, RN, Doug Schell, APRN, MSCN, Suzanne Carron, OTR/L, Salim Chahin, MD, MSCE